ANI Pharmaceuticals CEO Nikhil Lalwani Sells 5,400 Shares

What Happened
Nikhil Lalwani, President & CEO and director of ANI Pharmaceuticals (ANIP), sold 5,400 shares on 2026-09-15 at $71.00 per share for total proceeds of $383,400. This was a sale (not a purchase) executed in the open market/private sale.

Key Details

• Transaction date: 2026-09-15; Price: $71.00 per share; Total value: $383,400. (Code: S = Sale)
• Shares owned after the transaction: not specified in the provided filing excerpt.
• Footnote: Sale was made pursuant to a Rule 10b5-1 trading plan adopted May 26, 2026.
• Filing date: Form 4 filed 2026-09-16 (timely under Form 4 reporting rules).

Context
A Rule 10b5-1 plan indicates the transaction was made under a pre-established trading schedule, which is common for insider sales and can limit what the sale reveals about the insider’s current view of the company. Sales are generally considered less informative than purchases for signaling bullish conviction.